Found: 5
Select item for more details and to access through your institution.
Prognostic Value of the Combination of Circulating Tumor Cells Plus KRAS in Patients With Metastatic Colorectal Cancer Treated With Chemotherapy Plus Bevacizumab.
- Published in:
- Clinical Colorectal Cancer, 2013, v. 12, n. 4, p. 280, doi. 10.1016/j.clcc.2013.06.001
- By:
- Publication type:
- Article
Effect of antiangiogenic-based treatment and systemic inflammatory factors on outcomes in patients with BRAF v600-mutated metastatic colorectal cancer: a real-world study in Spain.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Efficacy and safety of FOLFIRI/aflibercept in second‐line treatment of metastatic colorectal cancer in a real‐world population: Prognostic and predictive markers.
- Published in:
- Cancer Medicine, 2019, v. 8, n. 3, p. 882, doi. 10.1002/cam4.1903
- By:
- Publication type:
- Article
Diagnosis delay and follow-up strategies in colorectal cancer. Prognosis implications: a study protocol.
- Published in:
- BMC Cancer, 2010, v. 10, p. 528, doi. 10.1186/1471-2407-10-528
- By:
- Publication type:
- Article
Rechallenge with Anti-EGFR Treatment in RAS/BRAF wt Metastatic Colorectal Cancer (mCRC) in Real Clinical Practice: Experience of the GITuD Group.
- Published in:
- Targeted Oncology, 2024, v. 19, n. 4, p. 565, doi. 10.1007/s11523-024-01062-z
- By:
- Publication type:
- Article